4//SEC Filing
KASPER F VAN 4
Accession 0001181431-09-049015
CIK 0000918112other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 4:09 PM ET
Size
7.2 KB
Accession
0001181431-09-049015
Insider Transaction Report
Form 4
KASPER F VAN
Director
Transactions
- Exercise/Conversion
Common Stock
2009-10-27$0.65/sh+15,000$9,750→ 58,600 total - Exercise/Conversion
Stock Option (Right to Buy)
2009-10-27−15,000→ 0 totalExercise: $0.65→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The Board of Directors of the Issuer approved acceleration of the vesting of all options so that the options become exercisable upon the approval of the dissolution of the Issuer by the stockholders. The stockholders of the Issuer approved the dissolution at a special meeting of stockholders held on October 27, 2009.
- [F2]Options will be terminated on the effective date of a certificate of dissolution of the Issuer to be filed with the Secretary of State of Delaware.
Documents
Issuer
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
CIK 0000918112
Entity typeother
Related Parties
1- filerCIK 0001277771
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 4:09 PM ET
- Size
- 7.2 KB